Familial mediterranean fever medicated with an herbal medicine in Japan

Pediatrics International

Volumn 46, Issue 1, 2004, Pages 81-84

  Komatsu, Masaki ^a   Takahashi, Tsutomu ^a   Uemura, Naoya ^b   Takada, Goro ^a  

^a AKITA UNIVERSITY   (Japan)

^b Yamamoto Kumiai General Hospital   (Japan)

Author keywords

Familial mediterranean fever; MEFV gene; Sho Saiko To (TJ 9)

Indexed keywords

GENOMIC DNA; HERBACEOUS AGENT; XIAO CHAI HU TANG;

ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; DNA EXTRACTION; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME; HERBAL MEDICINE; HUMAN; JAPAN; LABORATORY TEST; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; DNA MUTATIONAL ANALYSIS; DRUGS, CHINESE HERBAL; FAMILIAL MEDITERRANEAN FEVER; GENE FREQUENCY; HUMANS; JAPAN; MALE; MUTATION; PEDIGREE; PHYTOTHERAPY;

EID: 1542616526     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1328-0867.2004.01831.x     Document Type: Article

References (11)

1. Zemer D, Pras M, Sohar E, Gafni J. Colchicine in familial Mediterranean fever. N. Eng. J. Med. 1976; 294: 170-1.
2. Aksentijevich I, Torosyan Y, Samuels J et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am. J. Hum. Genet. 1999; 64: 949-62.
3. Cazeneuve C, Sarkisian T, Pecheux C et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am. J. Hum. Genet. 1999; 65: 88-97.
4. Yamashiki M, Kasaka Y, Nishimura A, Takase K, Ichida F. Efficacy of a herbal medicine 'Sho-Saiko-to' on the improvement of impaired cytokine production of peripheral blood mononuclear cells in patients with chronic viral hepatitis. J. Cli. Lab. Immunol. 1992; 37: 111-21.
5. Yamashiki M, Nishimura A, Suzuki H, Sakaguchi S, Kosaka Y. Effects of the Japanese herbal medicine 'Sho-Saiko-to' (TJ-9) on in Vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology 1997; 25: 1390-7.
6. Shimizu I, Ma YR, Mizoguchi Y et al. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 1999; 29: 149-60.
7. Oka H, Yamamoto S, Kuroki S et al. Prospective study of chemotherapy of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995; 76: 743-9.
8. Yano H, Mizoguchi A, Fukuda K et al. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 1994; 54: 448-54.
9. Centola M, Wood G, Frucht DM et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-31.
10. Richards N, Schaner P, Diaz A et al. International between Pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J. Biol. Chem. 2001; 276: 39320-9.
11. Ben-Chetrit E, Lerer I, Malamud E et al. The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum. Mut. 2000; 15: 385-6.